A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants

Clinical trial NCT05818709 · COMPLETED

Trial details

NCT number: NCT05818709
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Facial Volume Deficit

Start date: 2023-06-14
Primary completion: 2025-12-05
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.